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Abstract Glutaric acidurias are rare inherited neurodegener-
ative disorders accompanied by accumulation of the metab-
olites glutarate (GA) and 3-hydroxyglutarate (3OHGA),
glutaconate, L-, or D-2-hydroxyglutarate (L-2OHGA,
D-2OHGA) in all body fluids. Oocytes expressing the human
(h) sodium-dicarboxylate cotransporter (NaDC3) showed
sodium-dependent inward currents mediated by GA,
3OHGA, L-, and D-2OHGA. The organic anion transporters
(OATs) were examined as additional transporters for GA
derivatives. The uptake of [3H]p-aminohippurate in
hOAT1-transfected human embryonic kidney (HEK293)
cells was inhibited by GA, 3OHGA, D-, or L-2OHGA in a
concentration-dependent manner. None of these compounds
affected the hOAT3-mediated uptake of [3H]estrone sulfate
(ES). In hOAT4-expressing cells and oocytes, ES uptake was
strongly increased by intracellular GA derivatives. The data
provide a model for the concerted action of OAT1 and
NaDC3 mediating the basolateral uptake, and OAT4 medi-
ating apical secretion of GA derivatives from proximal
tubule cells and therefore contribute to the renal clearance of
these compounds.
Keywords NaDC3 . Organic anion transporters . OAT1 .
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Introduction
Several inborn metabolic diseases lead to the accumulation
of dicarboxylic acids such as glutaric acid. Glutaric aciduria
type 1 (GA1) is caused by deficiency of glutaryl-CoA
dehydrogenase (EC 1.3.99.7; GCDH), a mitochondrial
enzyme involved in the degradation of tryptophan and
lysine. Defective GCDH causes insufficient glutaryl-CoA
breakdown and results in an accumulation of glutaric acid
(GA), 3-hydroxyglutaric acid (3OHGA), glutaconate (GC),
and glutarylcarnitine in tissues, plasma, cerebrospinal fluid,
and urine [1–4]. During catabolic situations, GA1 patients
are subject to the development of encephalopathic crises,
leading to striatal degeneration with a subsequent irrevers-
ible dystonic–dyskinetic movement disorder. Histopatho-
logical findings include neuronal loss and astrogliosis in the
striatum, subdural hemorrhages, and spongiform vacuola-
tion of the white matter. These symptoms and the
associated histopathological changes in putamen and
caudatum mainly occur between the 3rd and 36th month
of age triggered by a nonspecific disease like fever,
respiratory infection, or diarrhea [1–5].
Glutaric aciduria type 2 (GA2) is an autosomal recessive
disorder associated with hypoketotic hypoglycemia, meta-
bolic acidosis, liver-, kidney-, and cardiomegaly, often
leading to an intractable neonatal illness with early death.
GA2 is caused by a defect of electron transfer flavoprotein
(ETF) or ETF cytochrome Q oxidoreductase and subse-
quent deficiencies of multiple acyl-CoA dehydrogenases.
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Defective fatty acid oxidation as well as amino acid
degradation led to accumulation of GA, lactate, and dicar-
boxylic acids such as ethylmalonate and adipate [6]. Two
other clinical entities, both affecting the nervous system, are
characterized by accumulation of D- and L-2-hydroxyglutaric
acids (D-2OHGA, L-2OHGA), respectively, in tissues and
body fluids [7–9]. Patients with D-2-hydroxyglutaric aciduria
suffer from developmental delay, macroencephalus, epilepsy,
and cerebral atrophy. Defects of either hydroxyacid–oxoacid
transhydrogenase or D-2OHGA dehydrogenase have been
observed in these patients. L-2-hydoxyglutaric aciduria is
caused by deficiency of the FAD-dependent L-2-hydroxy-
glutarate dehydrogenase and accompanied by psychomotor
retardation, ataxia, hypotonia, tremor, and seizures [10].
For diagnosis, newborn screening programs have been
developed based mainly on the detection of glutarylcarni-
tine in dried blood spots [11]. GA1 is considered treatable if
diagnosed before onset of encephalopathic crises. Patients
excrete with the urine large amounts of GA and 3OHGA
which exceeds glomerular filtration rate, indicating that
these substances have to be secreted [1].
At physiological pH, GA derivatives exist as highly
hydrophilic dicarboxylate anions requiring specific transport
systems to translocate these compounds across biological
membranes. Recently, we showed that GA, α-ketoglutarate
(αKG) [12], and 3OHGA [13] are substrates of the sodium
dicarboxylate cotransporter 3 (NaDC3, aliases NaC3,
SDCT2 [14]). Further renal transporters interacting with
αKG and GA are the organic anion transporters (OAT)1
and OAT3 located in the basolateral membrane and OAT4
in the apical membrane of proximal tubular cells [15–17].
OATs are in the focus of medical interest due to their roles
in the excretion of many clinically drugs such as antibiotics,
antivirals, H2 antagonists, antihypertensives, cytostatics,
diuretics, nonsteroidal anti-inflammatory drugs, statins,
and uricosurics [15–17]. In the present study, we report
on the capability of OATs to transport GA derivatives
across membranes. Since these transporters are present also
in the brain [18], OATs may not only influence plasma
levels of GA derivatives by securing their renal excretion
but may also have an important impact on their levels in
brain tissue.
Materials and methods
Solutions A standard oocyte Ringer solution (ORi) was
used for oocyte preparation, storage, and for the uptake as
well as for the electrophysiological measurements. ORi
contained (in mM): 110 NaCl, three KCl, two CaCl2, five
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES)/Tris adjusted to pH 7.5. All chemicals, including
those for ORi, for oocyte preparation and storage as well as
for the electrophysiological experiments on oocytes and the
uptake experiments on oocytes and HEK293 cells were
purchased from Sigma (Taufkirchen, Germany). 3OHGA
and [3H]3OHGA were kindly provided by J. Thiem
(Institute of Organic Chemistry, University of Hamburg,
Hamburg, Germany). Their synthesis was described in the
additional material provided electronically in [13]. Radio-
actively labeled [3H]estrone sulfate (ES, 43.5 Ci/mmol) and
[3H]para-aminohippurate (PAH, 4.18 Ci/mmol) were from
Perkin Elmer Life Sciences (Shelton, CT, USA).
In vitro transcription of cRNA hNaDC3 and hOAT4
cDNAs were used as templates for cRNA synthesis.
Plasmids were linearized with Not I and in vitro cRNA
transcription was performed using T7 mMessage mMa-
chine kit (Ambion, Austin, TX, USA) according to the
manufacturer’s instructions. The resulting cRNA was
suspended in purified, RNAse-free water to a final
concentration of 1 μg/μl.
Oocyte preparation and storage Female Xenopus laevis
(Nasco, Fort Atkinson, WI, USA) were subjected to partial
ovariectomy according to protocols approved by the Uni-
versitätsmedizin Göttingen, Medical Center Animal Care
and Use Committee. Stage V and VI oocytes were prepared
by an overnight treatment in ORi supplemented with
collagenase (Typ CLS II, Biochrom, Berlin, Germany).
Subsequently, after being washed with Ca2+-free ORi to
remove adhering follicle cells, the oocytes were injected
with 23 nl of 1 μg/μl cRNA coding for hNaDC3, hOAT4,
or water. Afterward, the injected oocytes were incubated at
16°–18°C in ORi supplemented with gentamycin (12 mg/
ml) and 2.5 mM sodium pyruvate. After 3 to 4 days of
incubation with daily medium changes, oocytes were used
for tracer uptake and electrophysiological studies.
hOAT1-, hOAT3-, and hOAT4-transfected HEK293 cells Hu-
man OAT1 and OAT3 (GeneBank accession number:
AF097490 and BI760120) were obtained from Resource
Center for Genome Research (RZPD, Berlin, Germany).
Human OAT4 (GeneBank accession number AL514126)
was from Invitrogen (Groningen, The Netherlands). The
stably transfected human epithelial kidney cells T-REX™-
HEK293-hOAT1, HEK293-hOAT3, and HEK293-hOAT4
were established by using the Flp-In™ expression system
(Invitrogen) as previously described [19]. Stably transfected
HEK293 cells were selected by hygromycine (10 μg/ml)
and grown in flasks in high glucose DMEM medium
(Invitrogen) supplemented with 10% fetal calf serum, 1%
penicillin/streptomycin, and blasticidine (5 mg/l; Sigma).
For control, the cells were transfected with the vector alone.
Cultures were maintained in humidified atmosphere that
contained 5% CO2 at 37°C.
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Electrophysiological experiments These studies were car-
ried out 3 days after cRNA injection at room temperature.
Oocytes were placed in a 0.5 ml bath chamber on the stage
of a dissecting microscope and impaled under direct view
with borosilicate glass (BioMedical Instruments, Zöllnitz,
Germany) microelectrodes filled with 3 M KCl. Current
recordings were made using the two electrode voltage
clamp technique in the voltage clamp mode with a
commercial amplifier (OC725, Warner, Hambden, CT,
USA). Borosilicate glass microelectrodes had resistances
of ∼1 MΩ.
Tracer uptake experiments HEK293-hOAT1, HEK293-
hOAT3, HEK293-hOAT4 and vector-transfected control cells
were harvested and plated into 24-well plastic dishes (Sarstedt,
Nürmbrecht, Germany) at a density of 2×105 cells/well.
Transport assays were performed 48 h after seeding in
mammalian Ringer solution that contained (in mM): 130
NaCl, four KCl, one CaCl2, one MgSO4, one NaH2PO4, 20
HEPES, and 18 glucose at pH 7.4. The cells were washed
twice with 0.5 ml Ringer and incubated for 5 min in Ringer
that contained 10 or 20 nM [3H]estrone sulfate for OAT3-
and OAT4-expressing HEK293 cells, or 1.2 μM [3H]PAH or
20 nM [3H]3OHGA for OAT1-expressing HEK293 cells.
Uptake was terminated by removal of the radioactive
medium and immediate 3×3 ml washes with ice-cold Ringer
solution. The cells were dissolved in 0.5 ml one N NaOH by
gently shaking for 120 min followed by neutralization with
0.5 ml one N HCl. The (3H) content was determined by
liquid scintillation counting (Tricarb 2900TR, Perkin Elmer,
Rodgau, Germany).
Some experiments required high intracellular concen-
trations of the GA derivatives within the cells or the
oocytes. For that purpose, OAT4-transfected HEK293 cells
were incubated for 2 h in Ringer containing in addition
1 mM 3OHGA, D-, or L-2OHGA. In a second set, oocytes
were injected with 23 nl of either 60 mM 3OHGA, D-, or L-
2OHGA or an equivalent amount of ORi (control).
Afterward, uptake experiments in cells were performed as
described above. The uptake of [3H]ES in oocytes was
measured as described previously [20].
Statistics Paired Student’s t-tests were used to show statis-
tically significant differences of GA derivative-associated
inward currents to the currents evoked by GA in the same
oocyte. The same test was also used for demonstrating
statistical significance of PAH or ES uptake in cis-inhibition
or trans-stimulation experiments. Statistical significance was
set at p<0.01. Ki values were determined by Dixon plot
analysis. To estimate the kinetic parameters for the transport
by hNaDC3, the equation I=Imax [S]/(Km+[S]) (SigmaPlot
10 software, Systat, Point Richmond, CA, USA) was used,
where I is the current actually measured, Imax the maximum
current, Km the Michaelis–Menten constant, and S the
substrate concentration.
Results
Substrate specificity for glutarate derivatives and other
dicarboxylates of human NaDC3 expressed in X. laevis
oocytes Perfusion of hNaDC3-expressing oocytes with L-,
D-2OHGA, GC, and adipate (each 1 mM) elicited inward
currents (Fig. 1). GA, αKG, and 3OHGA were used as
controls [13]. In the absence of sodium, these currents were
reduced by 81–99%, indicating their dependence on sodium
(Fig. 1). The magnitude of the steady state currents was a
saturable function of the concentration of the GA deriva-
tives (Fig. 2). Although the Km was the lowest for GA and
adipate (0.04 mM), the transport capacity (Imax) for D-, L-
2OHGA, and 3OHGA was greater than that for GA and
adipate (Table 1). For three distinct voltages −90, −60, and
−30 mV, the data were fitted to the Michaelis–Menten
equation and the Km values obtained were plotted as a
function of membrane potential (Fig. 2, bottom panel, right
side). For substitutions at position C2 (αKG, D-, and L-
2OHGA), Km was unaffected by the potential applied.
Substitutions at C3 (3OHGA) or introduction of a double
bound (GC) yielded comparably higher Km values at any
membrane potential. Furthermore, Km values for 3OHGA
and GC increased at depolarizing potentials.
Effect of various GA derivatives on PAH or ES uptake by the
human organic anion transporters OAT1, OAT3, andOAT4 In
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Fig. 1 Inward currents induced by GA derivatives in NaDC3-
expressing oocytes. At a holding potential of −60 mV, oocytes were
superfused with ORi or the indicated substrates (1 mM) in the
presence (black columns) or absence (gray columns) of sodium.
Substrate-associated currents, I, are presented as percent of the current
I produced by glutarate in the same batch of oocytes and are shown as
mean±SEM from n oocytes/m frogs: GA 17/11, αKG 4/3, L-2OHGA
4/3, D-2OHGA 4/3, 3OHGA 8/4, glutaconate 4/3, and adipate 4/3
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tightly coupled to the transport of organic anions via the
organic anion transporters OAT1, OAT3, and OAT4 [15,
16]. Therefore, the impact of GA derivatives on OAT-
mediated substrate transfer was investigated. HEK293 cells
transfected with the human OAT1, OAT3, or OAT4 cDNA
exhibited different inhibition patterns upon simultaneous
application of their prototypical substrate and GA deriva-
tives, adipate, or glutamate. Whereas [3H]PAH uptake in
hOAT1-transfected HEK293 cells was inhibited by more
than 80% of 0.1 mM GA, αKG, or adipate (Fig. 3a), these
compounds were less effective on hOAT3-mediated [3H]ES



















































































Fig. 2 Effect of membrane po-
tential on substrate-associated
inward currents and affinities of
NaDC3. Steady state substrate-
associated currents were mea-
sured as a function of three
different membrane potentials
(Vc: −90 (filled square), −60
(filled circle), −30 (filled trian-
gle) mV) using each of the
indicated substrate and five in-
dividual concentrations between
0.01 and 5 mM. Km was
obtained by fitting I=Imax [S]/
(Km+[S]) to the data. The results
represent the mean±SEM from
n oocytes/m frogs. The last
graph shows the calculated Km
values. For the GA derivatives,
the following symbols are used:
(4/3, unfilled square) glutaco-
nate; (7/5, filled inverted trian-
gle) 3OHGA; (5/3, unfilled
circle) glutarate and (3/3) adi-
pate; (4/4, filled circle) αKG; (5/
5, unfilled triangle) L-2OHGA;
(3/3, filled circle) D-2OHGA
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PAH uptake in OAT1-expressing cells significantly (Fig. 3a),
but showed no effects on OAT3-mediated [3H]ES uptake
(Fig. 3b). All compounds failed to impair the [3H]ES uptake
in OAT4-expressing HEK293 cells (Fig. 3c). The dicarbox-
ylic amino acid glutamate (0.1 mM) did neither inhibit [3H]
PAH nor [3H]ES uptake in cells transfected with OAT1,
OAT3, or OAT4 cDNA, respectively.
Inhibition of OAT1-mediated PAH uptake by 3OHGA, D-,
and L-2OHGA To analyze the kinetics of the inhibitory
effect of GA derivatives on hOAT1, Dixon plots were used.
In three independent experiments, a competitive inhibition
of PAH uptake by 3OHGA, D-2OHGA, and L-2OHGA was
observed (Fig. 4a,b,c) showing a Ki of 0.098±0.030 mM,
0.369±0.081 mM, and 0.748±0.032 mM, respectively.
Direct evidence of transport of 3OHGA, D-, and L-2OHGA
by hOAT1-transfected HEK293 cells Since 3OHGA
(0.1 mM) inhibited PAH uptake competitively, trans-
stimulation experiments with the GA derivatives on
OAT1-transfected HEK293 cells were performed (Fig. 5a).
All three GA derivatives increased [3H]PAH uptake
indicating exchange of PAH with either 3OHGA, D-, or L-
2OHGA. 3OHGAwhich showed the lowest Ki in the Dixon
plots (Fig. 4a), evoked the largest trans-stimulation. In
addition, transport of [3H]3OHGA (20 nM) in OAT1-
transfected HEK293 cells was assayed. The uptake of [3H]
3OHGA measured within 5 min was 3.8±1.6 pmol/5 min×
2×105 cells in hOAT1-transfected and 1.2±0.1 pmol/
5 min×2×105 cells in vector-transfected cells (Fig. 5b).
Despite the low concentration of labeled 3OHGA used,
uptake of 3OHGA was enhanced 3.1±1.4 times in OAT1-
transfected over vector-transfected cells.
Trans-stimulation of ES uptake by 3OHGA Because OAT4
accepted GA only from the intracellular compartment [20],
OAT4-transfected HEK293 cells were preincubated for 2 h
Table 1 Kinetic parameters for NaDC3 substrates





Glutarate 0.040±0.02 −45±1 1125±37 5/3
αKG 0.072±0.027 −28±2 452±135 4/4
L-2OHGA 0.267±0.048 −87±5 336±48 5/5
D-2OHGA 0.164±0.014 −138±4 847±58 3/3
3OHGA 0.93±0.25 −93±9 107±23 7/5
Glutaconate 1.44±0.31 −37±3 26±4 4/3
Adipate 0.040±0.003 −45±1 1129±82 3/3
Values are means±SEM from n oocytes of m donors. Km (Michaelis
constant) is the substrate concentration at half-maximal current; Imax is
the maximum current observed at saturating substrate concentrations
at a holding potential of −60 mV.
[3H]PAH uptake (%)





























































Fig. 3 Cis-inhibitory effects of dicarboxylates on uptake of [3H]PAH
and [3H]ES in HEK293 cells expressing OAT1 (a), OAT3 (b), or
OAT4 (c). The study was performed in Ringer solution without or
with 0.1 mM of the indicated dicarboxylates. The concentrations of
labeled substrates were 1.2 μM [3H]PAH (a) and 10 nM [3H]ES (b, c).
The gray columns represent the uptake in vector-transfected cells, and
the black columns represent OAT1-, OAT3-, or OAT4-expressing
HEK293 cells. All experiments were standardized by setting the
control (without inhibitor) of each experiment to 100%. The values
represent the mean±SEM of three independent experiments with four
repeats each. Significance calculated by Student’s t-test relative to
Ringer solution was accepted at p<0.01 (*)
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in solutions containing either 1 mM 3OHGA, D-, or L-
2OHGA to increase the intracellular concentration of these
compounds. Subsequent measurement of ES uptake for
5 min resulted in a trans-stimulation of [3H]ES uptake
(Fig. 6a) by a factor of 1.44±0.03, 1.54±0.02, 1.73±0.02,
indicating an exchange of 3OHGA, D-, and L-2OHGA
present within the cell against ES from the bath.
OAT4-expressing oocytes were injected with 3OHGA, L-,
and D-2OHGA to efficiently increase the intracellular
concentration of these compounds. When ES uptake in
buffer-injected oocytes was set to 100%, ES uptake was
increased by 3OHGA, L-, and D-2OHGA by a factor of
1.82±0.07, 2.38±0.26, and 2.11±0.21, respectively
(Fig. 6b).
Discussion
GA1 is caused by a defect in the mitochondrial glutaryl-
CoA dehydrogenase. Individuals suffering from GA1
exhibit high concentrations of GA and 3OHGA in their
body fluids and tissues. An additional increase in plasma
and brain concentrations of these metabolites during
catabolic crises is thought to be responsible for acute
striatal degeneration. Prerequesite for the cytotoxic effects
of GA and 3OHGA on brain and vascular cells [4, 21] is
the transport of metabolites across various biological
membranes, including mitochondrial and plasma mem-
branes and trans-endothelial transport.
Functional investigations in vitro recently demonstrated
the capability of the NaDC3 to translocate the GA1-specific
metabolite 3OHGA with low affinity [13]. Here, we show
that also L-, D-2OHGA, and GC evoked sodium-dependent
inward currents in X. laevis oocytes expressing hNaDC3.
Additionally, adipate, a metabolite accumulating in GA2,
showed a sodium-dependent inward current. The affinities
of hNaDC3 for these dicarboxylates decreased in the order
GA=adipate>αKG>D-2OHGA>L-2OHGA>3OHGA>
GC. This sequence indicates that hNaDC3 binds preferen-
tially unsubstituted dicarboxylates with five (GA) and six
carbon (adipate) backbones. A double bond within the
backbone as in GC largely decreased the affinity, suggest-
ing that the carbon backbone must be highly flexible for
interaction with hNaDC3. Substitutions at C2 (αKG,
c3OHGA (µM)
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Fig. 4 Dixon plot analysis for 3OHGA (a), D-2OHGA (b), and L-
2OHGA (c) on OAT1-mediated PAH uptake. OAT1-transfected
HEK293 cells were incubated in 10 μM (filled circle; 1.2 μM [3H]
PAH plus 8.8 μM unlabeled PAH) or 100 μM (unfilled circle; 1.2 μM
[3H]PAH plus 98.8 μM unlabeled PAH) PAH in the absence or
presence of dicarboxylates at the indicated concentrations. Each plot
shows a representative experiment out of a series of four independent
experiments for each experimental condition
b
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D-, and L-2OHGA) appeared to be better tolerated than a
substitution at C3 (3OHGA). The two dicarboxylates with
the lowest affinities (3OHGA, GC) exhibited a potential-
dependent Km, whereas unsubstituted and C2-substituted
dicarboxylates showed Km values independent of mem-
brane potential between −90 and −30 mV. The heavy metal
chelator, 2,3-dimercaptosuccinate, also had a Km increasing
with depolarization [22], suggesting that hNaDC3 has to
perform a voltage-dependent step in interacting with
compounds carrying a substitution at C3 or a double bond
between C2 und C3. The maximal currents, Imax, decreased
in the order D-2OHGA>3OHGA=L-2OHGA>GA=adipate>
GC>αKG. Thereby, the turnover rate of hNaDC3 with a
preference for OH substitutions at C2 and C3 appears to
follow a different sequence than the affinity. The transport
efficiency, Imax/Km, was the highest for adipate and GA,
followed by D-2OHGA>αKG>L-2OHGA>3OHGA»GC.
Thus, hNaDC3 may play an important role in the renal
secretion particularly of adipate, GA, and 2OHGAs, but not
for 3OHGA and GC. A reabsorption of these compounds by
hNaDC1 located in the apical [14] is unlikely, because




















































Fig. 5 Trans-stimulation of OAT1-mediated uptake by [3H]PAH and
direct evidence for [3H]3OHGA uptake by OAT1. Trans-stimulation
studies were performed by preloading OAT1-transfected HEK293
cells for 2 h with 1 mM of 3OHGA, D-, or L-2OHGA (a).
Subsequently, OAT1-mediated PAH-uptake (1.2 μM [3H]PAH plus
8.8 μM unlabeled PAH) was measured. Black columns represent the
uptake measured in OAT1 and gray columns such measured in vector-
transfected cells. The values represent means±SEM of four indepen-
dent repeats. Significance was calculated by Students t-test, *p<0.01.
In (b), the uptake of 20 nM [3H]OHGA in hNaDC3-transfected
HEK293 cells and mocks is compared. Data represent mean values of
three determinations, where the uptake of [3H]OHGA in hOAT1-












































Fig. 6 Trans-stimulation of OAT4-mediated uptake by [3H]estrone
sulfate. Trans-stimulation studies were performed by preloading (a)
OAT4-expressing HEK293 cells for 2 h with 1 mM of the indicated
effectors or (b) OAT4-expressing oocytes by injecting 23 nl of either
60 mM 3OHGA, D-, or L-2OHGA or an equivalent amount of ORi
(control). Subsequently, OAT4-mediated 20 nM [3H]ES uptake was
examined. The gray columns represent the uptake in vector-trans-
fected HEK293 cells (a) or mock-transfected oocytes (b). Black
columns represent uptake of radioactively labeled substrates by OAT4-
expressing HEK293 cells (a) or oocytes (b). All experiments were
standardized by setting the control (Ringer solution) of each
experiment to 100%. The values represent the mean±SEM of three
independent experiments with four repeats of cells or six to 15 oocytes
each. Significance was calculated by Students t-test, *p<0.01
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NaDC3 is not only localized in the basolateral mem-
brane of human and rat kidneys [24] but also in rat
astrocytes [25, 26] where it mediates αKG-inhibitable
transport of [14C]N-acetyl-L-aspartate, a compound with a
dicarboxylic acid like structure. It needs to be established
which role hNaDC3 plays in the brain of affected patients.
The multispecific OATs may represent additional candi-
dates for high affinity transporters of GA derivatives [15–
17]. In our studies, 3OHGA, D-, and L-2OHGA did not
interact with hOAT3 expressed in HEK293 cells, while
hOAT1 translocated [3H]3OHGA. [3H]PAH uptake in
HEK293 cells transfected with hOAT1 cDNA was marked-
ly reduced by 3OHGA, D-, L-2OHGA, and adipate in cis-
inhibition (competition) studies. Vive versa, [3H]PAH
uptake was increased by preloading these cells with
3OHGA and D-, or L-2OHGA indicating exchange of
PAH with either 3OHGA, D-, or L-2OHGA. These
observations provide the first evidence that OAT1 not only
interacts with its natural substrate αKG but also with
glutarates possessing hydroxyl groups at position C2 or C3.
All GA derivatives exhibited competitive inhibition with
PAH. 3OHGA showed a Ki much lower than D- or L-
2OHGA, suggesting that a C3-substituted dicarboxylate
may fit better into the binding pocket of hOAT1 than
dicarboxylates with substitutions at C2. Glutamate and GC
at a concentration of 0.1 mM only weakly interacted with
hOAT1 indicating that positively charged substitutions, the
amino group in glutamate, or a double bound in the carbon
backbone (GC) do not fulfill an ideal configuration for
substrates of hOAT1. Acceptance of dicarboxylates by
hOAT1 is not restricted to C5 carbon backbone dicarbox-
ylates as demonstrated by inhibition of PAH uptake by
adipate (C6). A higher chain length (pimelate; C7 and
suberate; C8) is not suitable for transport (data not shown).
Suberate, present in the urine of GA2 patients, has to be
excreted by transporters different from OAT1.
3OHGA, D-, and L-2OHGA did not interact with OAT3.
These substances also did not inhibit OAT4, but trans-
stimulated ES uptake into OAT4-transfected cells or OAT4-
expressing oocytes. Recently, we have shown that OAT4
which is located at the apical membrane of human proximal
tubule cells is working in an asymmetric mode: it accepts
dicarboxylates only from the inside (cytosolic side), but not
from the outside (urine side) [20]. One of the physiological
functions of OAT4 is the reabsorption of estrone sulfate and
urate from the filtrate in exchange for intracellular
dicarboxylates. Here, we provide experimental evidence of
an exchange between extracellular ES and intracellular
3OHGA, L-, and D-2OHGA mediated by OAT4.
Our observations describe for the first time the basic
components of the renal secretion of cytotoxic metabolites
accumulating in patients suffering from glutaric acidurias.
These data are summarized in a cell model for the renal
excretion of GA and GA derivatives in Fig. 7. GA and GA
derivatives are taken up from the plasma across the
basolateral membrane by OAT1 and NaDC3 and are secreted
into the urine via OAT4. It is, however, likely that NaDC3 is
not only directly involved in the uptake of 3OHGA and
2OHGAs but mediates the transfer of αKG into proximal
tubule cells to supply anionic exchange equivalents for
OAT1. The coordinated action of these transporters may
guarantee a high renal clearance of GA and GA derivatives
under metabolically stable conditions. In states of fever,
however, downregulation of the expression of OAT1 [27]
may partially impair renal secretion and cause accumulation


















Fig. 7 Cell model for the renal
secretion of GA derivatives. GA
derivatives are taken up from the
plasma by OAT1 and NaDC3
across the basolateral membrane
and exit the cell by OAT4 in
exchange for estrone sulfate or
the more physiological anion
chloride. The gradient required
for sodium-dependent uptake
via NaDC3 is maintained by the
Na+/K+-ATPase
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